Skip to main content
Top
Published in: AIDS and Behavior 2/2015

01-02-2015 | Original Paper

Disclosure of Their Status to Youth with Human Immunodeficiency Virus Infection in the Dominican Republic: A Mixed-Methods Study

Authors: Consuelo Beck-Sagué, Maria Claudia Pinzón-Iregui, Rosa Abreu-Pérez, Leonel Lerebours-Nadal, Christi M. Navarro, Gladys Ibanez, Solange Soto, Mina Halpern, Stephen W. Nicholas, Robert Malow, Jessy G. Dévieux

Published in: AIDS and Behavior | Issue 2/2015

Login to get access

Abstract

A mixed-methods study was conducted to determine the proportion of HIV-infected children who knew their status, identify characteristics associated with children’s knowledge of their status, and describe caregivers’ and adolescents’ experiences relevant to disclosure in the Dominican Republic (DR). Of 327 patients aged 6–18 years treated in the principal DR pediatric HIV facilities, 74 (22.6 %) knew their status. Patients aged 13 years or older and/or who had participated in non-clinical activities for HIV-infected children were more likely to know their status. Caregivers who had disclosed cited healthcare providers’ advice, children’s desire to know and concerns that children might initiate sexual activity before knowing or discover their status by accidental or malicious disclosure. Non-disclosing caregivers worried that children would be traumatized by disclosure and/or stigmatized if they revealed it to others. Adolescents supported disclosure by 10–12 years of age, considered withholding of children’s HIV diagnosis ill-advised, and recommended a disclosure process focused initially on promoting non-stigmatizing attitudes about HIV.
Appendix
Available only for authorised users
Literature
4.
go back to reference Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522–8.CrossRefPubMed Gortmaker SL, Hughes M, Cervia J, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 2001;345:1522–8.CrossRefPubMed
5.
go back to reference Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in Sub-Saharan Africa. Lancet Infect Dis. 2008;8:477–89.CrossRefPubMed Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in Sub-Saharan Africa. Lancet Infect Dis. 2008;8:477–89.CrossRefPubMed
7.
go back to reference American Academy of Pediatrics. Disclosure of illness status to children and adolescents with HIV infection. Pediatrics. 1999;103:164–6.CrossRef American Academy of Pediatrics. Disclosure of illness status to children and adolescents with HIV infection. Pediatrics. 1999;103:164–6.CrossRef
8.
go back to reference Qiao S, Li X, Stanton B. Disclosure of parental HIV infection to children: a systematic review of global literature. AIDS Behav. 2013;17:369–89.CrossRefPubMed Qiao S, Li X, Stanton B. Disclosure of parental HIV infection to children: a systematic review of global literature. AIDS Behav. 2013;17:369–89.CrossRefPubMed
9.
go back to reference Pinzón-Iregui MC, Beck-Sagué CM, Malow RM. Disclosure of their HIV status to infected children: a review of the literature. J Trop Pediatr. 2013;59:84–9.CrossRefPubMedCentralPubMed Pinzón-Iregui MC, Beck-Sagué CM, Malow RM. Disclosure of their HIV status to infected children: a review of the literature. J Trop Pediatr. 2013;59:84–9.CrossRefPubMedCentralPubMed
10.
go back to reference Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM. Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc. 2013;16:18466.CrossRefPubMedCentralPubMed Vreeman RC, Gramelspacher AM, Gisore PO, Scanlon ML, Nyandiko WM. Disclosure of HIV status to children in resource-limited settings: a systematic review. J Int AIDS Soc. 2013;16:18466.CrossRefPubMedCentralPubMed
12.
go back to reference Arun S, Singh A, Lodha R, Kabra S. Disclosure of the HIV infection status to children. Indian J Pediatr. 2009;76:805–13.CrossRefPubMed Arun S, Singh A, Lodha R, Kabra S. Disclosure of the HIV infection status to children. Indian J Pediatr. 2009;76:805–13.CrossRefPubMed
13.
go back to reference Biadgiling S, Deribew A, Amberbir A, Ruisenor-Escudero H, Deribe K. Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multicenter study in Addis Ababa, Ethiopia. PLoS One. 2011;6:e17572.CrossRef Biadgiling S, Deribew A, Amberbir A, Ruisenor-Escudero H, Deribe K. Factors associated with HIV/AIDS diagnostic disclosure to HIV infected children receiving HAART: a multicenter study in Addis Ababa, Ethiopia. PLoS One. 2011;6:e17572.CrossRef
14.
go back to reference Bikaako-Kajura W, Luyirika E, Purcell D, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 Suppl):S85–93.CrossRefPubMed Bikaako-Kajura W, Luyirika E, Purcell D, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav. 2006;10(4 Suppl):S85–93.CrossRefPubMed
15.
go back to reference Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: Implications for peer-support programs. J Acquir Immune Defic Syndr. 2007;46:349–54.CrossRefPubMed Menon A, Glazebrook C, Campain N, Ngoma M. Mental health and disclosure of HIV status in Zambian adolescents with HIV infection: Implications for peer-support programs. J Acquir Immune Defic Syndr. 2007;46:349–54.CrossRefPubMed
16.
go back to reference Mendoza R, Castillo R, Rodriguez MC, et al. Información que sobre su enfermedad reciben los niños VIH positivos. Boletín del Centro Nacional de Investigaciones en Salud Materno Infantil (CENISMI). 2006;16:7–11. Mendoza R, Castillo R, Rodriguez MC, et al. Información que sobre su enfermedad reciben los niños VIH positivos. Boletín del Centro Nacional de Investigaciones en Salud Materno Infantil (CENISMI). 2006;16:7–11.
17.
go back to reference Blasini I, Chantry C, Cruz C, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004;25:181–9.CrossRefPubMed Blasini I, Chantry C, Cruz C, et al. Disclosure model for pediatric patients living with HIV in Puerto Rico: design, implementation, and evaluation. J Dev Behav Pediatr. 2004;25:181–9.CrossRefPubMed
21.
go back to reference Neuendorf KA. The content analysis guidebook. Thousand Oaks: Sage Publications; 2002. Neuendorf KA. The content analysis guidebook. Thousand Oaks: Sage Publications; 2002.
22.
go back to reference Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15:1121–7.CrossRefPubMedCentralPubMed Kallem S, Renner L, Ghebremichael M, Paintsil E. Prevalence and pattern of disclosure of HIV status in HIV-infected children in Ghana. AIDS Behav. 2011;15:1121–7.CrossRefPubMedCentralPubMed
25.
go back to reference Ferris M, Burau K, Schweitzer A, et al. The influence of disclosure of HIV diagnosis on time to disease progression in a cohort of Romanian children and teens. AIDS Care. 2007;19:1088–94.CrossRefPubMed Ferris M, Burau K, Schweitzer A, et al. The influence of disclosure of HIV diagnosis on time to disease progression in a cohort of Romanian children and teens. AIDS Care. 2007;19:1088–94.CrossRefPubMed
26.
go back to reference Sohn AH, Hazra R. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc. 2013;18(16):18555. Sohn AH, Hazra R. The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc. 2013;18(16):18555.
27.
go back to reference Gillard A, Witt P, Watts C. Outcomes and processes at a camp for youth with HIV/AIDS. Qual Health Res. 2011;21:1508–20.CrossRefPubMed Gillard A, Witt P, Watts C. Outcomes and processes at a camp for youth with HIV/AIDS. Qual Health Res. 2011;21:1508–20.CrossRefPubMed
31.
go back to reference Sherman BF, Bonanno GA, Wiener LS, Battles HB. When children tell their friends they have AIDS: possible consequences for psychological well-being and disease progression. Psychosom Med. 2000;62:238–47.CrossRefPubMed Sherman BF, Bonanno GA, Wiener LS, Battles HB. When children tell their friends they have AIDS: possible consequences for psychological well-being and disease progression. Psychosom Med. 2000;62:238–47.CrossRefPubMed
32.
go back to reference Mason HR, Marks G, Simoni JM, Ruiz MS, Richardson JL. Culturally sanctioned secrets? Latino men’s nondisclosure of HIV infection to family, friends, and lovers. Health Psychol. 1995;14:6–12.CrossRefPubMed Mason HR, Marks G, Simoni JM, Ruiz MS, Richardson JL. Culturally sanctioned secrets? Latino men’s nondisclosure of HIV infection to family, friends, and lovers. Health Psychol. 1995;14:6–12.CrossRefPubMed
Metadata
Title
Disclosure of Their Status to Youth with Human Immunodeficiency Virus Infection in the Dominican Republic: A Mixed-Methods Study
Authors
Consuelo Beck-Sagué
Maria Claudia Pinzón-Iregui
Rosa Abreu-Pérez
Leonel Lerebours-Nadal
Christi M. Navarro
Gladys Ibanez
Solange Soto
Mina Halpern
Stephen W. Nicholas
Robert Malow
Jessy G. Dévieux
Publication date
01-02-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 2/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-014-0888-7

Other articles of this Issue 2/2015

AIDS and Behavior 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine